Background Mechanisms underlying the previously reported association between a deletion polymorphism in the gene encoding for angiotensin-converting enzyme (ACE) and the risk of myocardial infarction in low-risk subjects are unclear. The purpose of this case-control study was to examine the relation of plasma ACE activity to intimal-medial thickness of the carotid wall measured ultrasonographically in an apparently healthy population.
showed a slight but not significant increase in plasma ACE activity in comparison with control subjects (P<.16). However, after exclusion of subjects receiving lipid-lowering drugs, the mean plasma ACE activity became significantly higher in cases than in control subjects (29.9+7.7 U/L versus 27.5±8.0 U/L; n=54 pairs, P<.03). The mean case-control difference in plasma ACE activity was further increased when analysis was restricted to pairs without carotid atheromatous plaques (n=42 pairs). After adjustment for body mass index, smoking, and systolic blood pressure, the odds ratio for having carotid wall thickening based on 1 SD difference in log ACE was 2.29 (95% confidence interval, 1.16 to 4.52; P<.02).
Conclusions The results of the study suggest that chronic exposure to high levels of plasma ACE could be involved in structural changes of the arterial wall. (Circulation. 1994;89: 952-954.)
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The opportunity to test the hypothesis that increased plasma ACE activity is associated with common carotid wall thickening was offered to us in an ongoing population-based ultrasonographic study on vascular aging. We considered that a case-control design was the most straightforward way to verify this hypothesis.
Methods
The EVA study is a longitudinal study on cognitive and vascular aging performed in volunteers aged 60 to 69 years recruited from the electoral rolls of the city of Nantes (western France). The study protocol was approved by the Comite d'ethique du Centre Hospitalier Universitaire de KremlinBicetre, and written informed consent was obtained from all participants. Between June 1991 and January 1993, 1036 subjects (434 men and 602 women) were examined. Information about demographic background, occupation, personal and family history, drug use, and cigarette smoking was obtained by a standardized questionnaire. Only subjects (n=717) who did not report any history of myocardial infarction and angina pectoris or any treatment for hypertension or diabetes constituted the population from which cases and control subjects were selected. However, subjects receiving lipid-lowering drugs (18. 7% of this population) were not excluded.
High-resolution B-mode ultrasound examination of the carotid arteries was performed by four sonographers with a 7.5-MHz transducer (SSD-650, Aloka). Acquisition, processing, and storage of B-mode images were computer assisted with specially designed software.'2 The protocol involved scanning of the common carotid arteries, the carotid bifurcations, and the origin (first 2 cm) of the internal carotid arteries. On a longitudinal B-mode image of the common carotid artery, the far wall is displayed as two parallel bright lines separated by a hypoechoic space. The first line on the far wall Bonithon-Kopp et al Plasma ACE Activity and Carotid Wall Thickening arises from the lumen-intima interface, whereas the second line arises from the media-adventitia interface. Thus, the distance between the media-adventitia interface and the lumen-intima interface represents the intimal-medial thickness (IMT). 
Results
Among the 80 case-control pairs, the mean IMT (standard deviation) was 0.94 mm (0.12) and 0.58 mm (0.08) in cases and control subjects, respectively. Although cases had slightly higher plasma ACE activity than control subjects, the mean difference between them did not reach the significance level (1.3±10.6 U/L, P<.16). We further examined whether the association between plasma ACE activity and increased IMT was more pronounced in subjects not receiving lipid-lowering drugs (exclusion of 12 cases and 17 control subjects corresponding to 26 pairs). The Figure shows the distribution of plasma ACE activity among the 54 remaining pairs. There was an excess of cases among subjects with intermediate plasma ACE levels (between 28 and 40 U/L), an excess of control subjects among those with low plasma ACE levels, and a roughly equal frequency of cases and control subjects among those with high plasma ACE levels. As shown in Table 1 , the mean plasma ACE activity was significantly higher in cases than in control subjects (P<.03). Among pairs without carotid atheromatous plaques (n=42), the mean case-control difference in plasma ACE activity was further increased and became highly significant (P<.005). Conversely, among pairs with plaques (n= 12), cases tended to show lower plasma ACE activity than did control subjects. Age was comparable in both groups, This study suggests that chronic exposure to high levels of plasma ACE may be involved in structural changes of the arterial wall independent of classic risk factors for atherosclerosis. Further investigations are required to assess the clinical relevance of this finding.
